RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Jun 8, 2026, 9:05 AM EST
RAMM Pharma Cash Flow Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Net Income | -8.65 | -8.91 | -16.5 | -7.72 | -20.96 | -7.11 |
Depreciation & Amortization | 0.61 | 0.73 | 1.21 | 1.34 | 1 | 0.72 |
Other Amortization | 0 | 0 | 0 | - | 0.02 | 0.02 |
Loss (Gain) From Sale of Assets | -0.98 | -0.77 | - | - | - | -0.03 |
Asset Writedown & Restructuring Costs | 4.77 | 4.77 | 7.56 | 1.07 | 13.18 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.23 | -0.27 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.71 |
Stock-Based Compensation | - | - | 0.17 | 0.01 | 0.38 | 0.7 |
Provision & Write-off of Bad Debts | -0.01 | 0.01 | -0.06 | -0.01 | 0.07 | 0.1 |
Other Operating Activities | 0.3 | 0.44 | 2.16 | 1.34 | 0.09 | 0.34 |
Change in Accounts Receivable | 1.49 | 1.08 | 0.4 | 0.51 | 1.51 | -0.22 |
Change in Inventory | 0.75 | 1.02 | 0.58 | -0.33 | -0.09 | 0.51 |
Change in Accounts Payable | 0.57 | 0.57 | 0.49 | -0.54 | -1.34 | 0.69 |
Change in Income Taxes | 0 | -0 | 0 | - | -0 | 0 |
Operating Cash Flow | -1.14 | -1.06 | -4 | -4.34 | -5.91 | -3.83 |
Capital Expenditures | 0.03 | - | -0.05 | -0.06 | -0.17 | -0.43 |
Sale of Property, Plant & Equipment | 1.76 | 1.22 | - | 0.15 | 0.04 | 0.03 |
Cash Acquisitions | - | - | - | - | -1.11 | 3.31 |
Investment in Securities | - | - | - | - | - | -10 |
Other Investing Activities | - | - | - | 0.04 | 0.09 | 0.26 |
Investing Cash Flow | 1.79 | 1.22 | -0.05 | 0.13 | -1.15 | -6.83 |
Long-Term Debt Repaid | - | -0.15 | -0.26 | -0.29 | -0.13 | -0.08 |
Net Debt Issued (Repaid) | -0.1 | -0.15 | -0.26 | -0.29 | -0.13 | -0.08 |
Repurchase of Common Stock | - | - | - | -0.17 | -0.22 | -0.09 |
Other Financing Activities | -0.01 | -0.01 | - | - | - | - |
Financing Cash Flow | -0.11 | -0.15 | -0.26 | -0.46 | -0.35 | -0.18 |
Foreign Exchange Rate Adjustments | -0.04 | -0.01 | 0 | 0.01 | 0.04 | -0.01 |
Net Cash Flow | 0.5 | -0.01 | -4.3 | -4.66 | -7.38 | -10.85 |
Free Cash Flow | -1.11 | -1.06 | -4.05 | -4.4 | -6.08 | -4.26 |
Free Cash Flow Margin | -43.32% | -31.54% | -93.17% | -86.87% | -156.02% | -103.52% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.04 | -0.05 | -0.04 |
Cash Interest Paid | 0.25 | 0.25 | 0.04 | - | - | - |
Cash Income Tax Paid | 0.02 | 0.02 | 0.01 | - | - | - |
Levered Free Cash Flow | 1.04 | 1.03 | -2.86 | -2.31 | -3.79 | -5.03 |
Unlevered Free Cash Flow | 1.19 | 1.18 | -2.84 | -2.28 | -3.79 | -5.02 |
Change in Working Capital | 2.81 | 2.67 | 1.47 | -0.37 | 0.08 | 0.98 |